Abstract
and increased expression of the intermediate filaments protein, glial fibrillary acidic protein (GFAP) (Hol & Penky, 2015; Sofroniew, 2009; Zamanian et al., 2012) . Accumulating evidence indicates that astrogliosis could be involved in exacerbating injury and/or tissue repair depending on the brain injury time and context (Colombo & Farina, 2016) . Upon ischemic stroke, reactive astrocytes are known to amplify injury via the release of neurotoxic levels of reactive oxygen species, exacerbate inflammation via cytokine production, compromise BBB function via VEGF production, and aggravate cytotoxic edema through stimulation of AQP4 (Argaw, Gurfein, Zhang, Zameer, & John, 2009; Brambilla et al., 2005; Cengiz et al., 2014; Swanson, Ying, & Kauppinen, 2004; Zador, Stiver, Wang, & Manley, 2009 ). Concomitantly, reactive astrocytes are also involved in tissue repair via secretion of anti-inflammatory factors, uptake of excess glutamate and isolation of undamaged tissue (Kim, Min, Seol, Jou, & Joe, 2010; Li et al., 2008; Wanner et al., 2013) . The complex aspects of astrogliosis function drive profound interest in developing a better understanding of the signals regulating reactive astrogliosis and, in particular, in searching for the molecular targets that promote tissue functional recovery, which is comprehensively reviewed by Liu, Teschemacher, and Kasparov (2017) . Previous studies indicate that deletion or inactivation of astrocyte-specific TGFb signaling in mice exacerbates motor function deficits and glial scar formation without altering overall disease severity after ischemic stroke (Cekanaviciute et al., 2014) . Selective deletion of Notch 1 signaling in astrocytes was shown to reduce astrocyte proliferation in the ischemic peri-infarct region at 24 hr of reperfusion, but the functional outcomes were not evaluated (Shimada, Borders, Aronshtam, & Spees, 2011) . Selective deletion of STAT3 in reactive astrocytes also results in increased white matter damage, neuronal death, and slower motor recovery after spinal cord injury (Okada et al., 2006; Herrmann et al., 2008) . In contrast, conditional knockout of p38 MAPK in GFAP-Cre/loxp mice prevented astrocytic hypertrophy and GFAP upregulation and enhanced motor functional recovery after ischemic stroke (Roy Choudhury et al., 2014) .
These findings suggest that multiple but distinct signaling cascades are involved in regulating reactive gliosis and have differential impacts on neurological damage and recovery of neurological function after brain injury.
In this study, we investigated roles of astrocytic Na 1 /H 1 exchanger isoform 1 (NHE1) in reactive astrocyte formation and in neurological damage after ischemic stroke. NHE1 protein represents a major pathway for H 1 extrusion in exchange for Na 1 in astrocytes (Kirischuk, Parpura, & Verkhratsky, 2012; Rose & Karus, 2013) . Our previous studies show that oxygen-glucose deprivation of cortical astrocytes leads to sustained NHE1 activation, resulting in Na 1 overload and swelling (Kintner et al., 2004; Luo, Chen, Kintner, Shull, & Sun, 2005) . Genetic ablation of Nhe1 or pharmacological inhibition with its potent inhibitor HOE 642 protects against astrocyte damage (Kintner et al., 2004; Luo et al., 2005; Yao, Ma, Gu, & Haddad, 1999 ). These findings demonstrate the importance of astrocytic NHE1 in ischemic astrocyte injury. However, as NHE1 is expressed in all cell types, using either the global Nhe1 knockout or pharmacological inhibition of NHE1 does not allow a detailed analysis of the specific roles of astrocytic NHE1 protein in astrocyte dysfunction after ischemic stroke. In this study, we created an Nhe1 ; Nhe1 f/f mice led to reduced stroke volume, inhibition of reactive astrocyte formation, and improved neurological function after ischemic stroke. Our study shows for the first time that deletion of Nhe1 gene specifically in astrocytes has a beneficial effect in ischemic stroke. 
| Mice and genotyping
All studies were in compliance with the guidelines outlined in the Guide 
| Generation of
The Gfap-Cre ERT21/2 transgenic mouse line (C57BL/6 genetic background) was generated as described previously (Ganat et al., 2006) and purchased from Jackson Laboratory (Stock # 012849). The mice express a Cre recombinase-estrogen receptor type 2 fusion protein (CreERT2) in radial glia, astrocytes, and neuro stem cells under control of the Gfap2 upstream fragment of the human Gfap (hGfap) promoter (Ganat et al., 2006) . Genotyping was done by PCR using primers to the Cre gene (5 0 -GCA ACG AGT GAT GAG GTT CGC AAG-3 0 , forward; 5 0 -TCC GCC GCA TAA CCA GTG AAA CAG-3 0 , reverse) to generate a band of 307 bp (Ganat et al., 2006) . ;Nhe1 f/f mice.
Astrocyte-specific knockout of Nhe1 was induced by a 5 day i.p. injection of tamoxifen (Tam) in corn oil at a dosage of 75 mg/kg (i.p.) starting at postnatal day 60-90 (P60-90). Mice injected with corn oil only served as controls. Scientists were blinded to the allocation of the mice to the groups. Litters were caged in mixed groups after i.p. injection with either corn oil or Tam and also upon surgery. Animals for experiments were gender and age matched. A total of 80 mice used for the study consisted of 8-12-week-old males (n 5 56; weight: 20 6 0.5 g) and females (n 5 40, weight: 25 6 0.2 g). For analyses of infarct volume measurement, 12 mice in total were used (male oil: n 5 3; female oil:
n 5 2; male tam: n 5 5; female tam: n 5 2). Behavioral studies and immunocytochemical analyses were performed on the same cohort of animals and brain samples were extracted at different experimental times. Mice were excluded from the study if they died prior to 24 hr reperfusion (n 5 6). 
| Middle cerebral artery occlusion and reperfusion
Transient focal cerebral ischemia was induced by intraluminal occlusion of left middle cerebral artery (MCA), as previously described (Begum et al., 2015) . Under 1.5% isoflurane, the left common carotid artery (CCA) was exposed via a midline pretracheal incision and the external carotid artery (ECA) and the CCA were ligated. To occlude the MCA, a rubber silicon-coated monofilament suture (Filament size 6-0, diameter 0.09-0.11 mm, length 20 mm; diameter with coating 0.21 6 0.02 mm;
coating length 5 mm) was inserted into the ECA and advanced along the internal carotid artery 8-10 mm from the bifurcation of the carotid artery. For reperfusion, the suture was gently withdrawn 60 min after ischemia. Tympanic membrane and rectal temperature probes were inserted and cranial and body temperatures were maintained at 36.5 6 0.5 8C throughout the experiment by a heating blanket.
| Regional cerebral blood flow (rCBF) measurements
Cerebral blood flow was monitored using a two-dimensional laser speckle contrast analysis system (PeriCam PSI High Resolution with PIMSoft; Perimed, Järfälla, Sweden). Mice were anesthetized with isofluorane and maintained at physiological body temperature as 
| Measurement of infarct volume
Infarct volume was determined by 2,3,5-triphenyl-tetrazolium chloride (TTC) staining at 48 hr reperfusion, as described before (Begum et al., 2015) . Infarction volume was quantified using Imaje J software as described previously (Swanson et al., 1990) . The extent of hemispheric swelling was calculated using the equation "volume of ipsilateral hemisphere 2 volume of contralateral hemisphere/volume of contralateral hemisphere."
| Evaluation of Evans blue dye extravasation
Changes in the BBB permeability were assessed by the leakage of Evans blue (EB) into the brain parenchyma following intravenous injection of EB dye (2% in PBS, 10 ll/g body weight at 22 hr reperfusion). EB (961 Da dye) strongly binds to the albumin fraction of proteins to form a high-molecular-weight complex (68.5 kDa) and EB complex does not permeate the intact BBB unless the BBB is compromised after stroke (Belayev, Busto, Zhao, & Ginsberg, 1996 
| Cerebral blood vessel isolation
Cerebral blood vessels were isolated from mouse brains as described previously (Boulay, Saubamea, Decleves, & Cohen-Salmon, 2015) .
Briefly, 48 hr after MCAO, mice were anesthetized with 3% isfluorane and decapitated and placed in HBSS containing 1 M HEPES. The choroid plexus was dissected out from the lateral ventricles and the CL and IL cortices were separated. The brain tissue was then chopped into small pieces and gently homogenized with an automatized Dounce homogenizer (20 strokes at 400 rpm) in HBSS, followed by centrifugation at 2,000g for 10 min at 4 8C. Pellets were resuspended in HBSS with 18% dextran (MW 70,000) and centrifuged at 4,400g for 15 min at 4 8C. Pelleted blood vessels were collected on top of a nylon mesh (20 lm) and washed extensively with HBSS containing 1% BSA. The vessels were resuspended in ice cold HBBS with 1% BSA and centrifuged at 2,000g for 5 min at 4 8C. Isolated vessels were processed immediately for immunostaining as described previously (Boulay et al., 2015) . Vessels were incubated with primary antibodies for occludin
(1:100) overnight at 4 8C followed by goat antimouse Alexa 488-conjugated secondary antibodies for 1 hr at room temperature (RT). Images were captured using Leica DMIRE2 inverted confocal laser scanning microscope. The results were expressed in arbitrary units. 
| Immunofluorescent staining and image analysis

| BrdU immunostaining analysis
| Transmission electron microscopy
Structural integrity of cerebral microvessels was analyzed in the CL and IL peri-infarct areas in the cortex as described previously (Kimbrough, Robel, Roberson, & Sontheimer, 2015) with modifications. Briefly, mice were transcardially perfused with PBS followed by fixation with 4%
PFA for 24 hr. After fixation, the brain was removed and sectioned into 1-mm-thick slices and postfixed in 2.5% glutaraldehyde in PBS. Under a dissection microscope, tissue punches were taken to capture the IL and CL peri-infarct areas in the cortex. Tissues were washed three times in PBS then, postfixed in 1% osmium tetroxide with 1% potassium ferricyanide for 1 hr. Following three additional PBS washes, the pellet was dehydrated through a graded series of 30%-100% ethanol, 100% propylene oxide and then infiltrated in 1:1 mixture of propylene oxide: Polybed 812 epoxy resin for 1 hr. After several changes of 100% resin over 24 hr, pellet was embedded in a final change of resin, cured at 37 8C overnight, followed by additional hardening at 65 8C for two more days. Ultrathin (70 nm) sections were collected on 200 mesh copper grids, stained with 2% uranyl acetate in 50% methanol for 10 min, followed by 1% lead citrate for 7 min. Sections were imaged using a JEOL JEM 1011 transmission electron microscope (Peabody, MA) at 80 kV fitted with a side mount AMT 2k digital camera (Advanced Microscopy Techniques, Danvers, MA).
| Neurological function tests
Neurological functional deficits in mice were screened in a blinded manner with the following tests: neurological score, corner test, adhesive removal test, and rotarod test, all considered reliable for identifying and quantifying sensorimotor deficits and postural asymmetries (Schaar, Brenneman, & Savitz, 2010; Zhang et al., 2002) .
| Neurological score
A neurological deficit grading system was used to evaluate neurological deficit at 1-5 days after MCAO as described previously (Zhang et al., 2002) according to the following scale: 0 5 no observable deficit; 1 5 forelimb flexion; 2 5 forelimb flexion and decreased resistance to lateral push; 3 5 forelimb flexion, decreased resistance to lateral push, and unilateral circling; and 4 5 forelimb flexion and impaired or absent ambulation.
| Adhesive removal test
The adhesive removal test, the most effective assessment of sensorimotor function impairments after ischemic stroke (Bouet et al., 2007 (Bouet et al., , 2009 ), was used to measure somatosensory deficits as described previously (Zhao et al., 2016) . Two pieces of adhesive tape (4 3 3 mm 2 )
were attached to the forepaws in an alternating sequence and with equal pressure by the experimenter before each trial. The mouse was placed in a transparent plastic box and the times to contact and to remove each adhesive tape were collected with a maximum of 120 s.
Experimenters were blind with regard to the mice groups. Preoperative training was carried twice per day for 3 days. Animals were tested on Days 1, 2, 3, 4, and 5 after MCAO. Two parameters were monitored for each paw: contact time (point that the mouse reacts to the presence of adhesive strips) and adhesive removal point.
| Rotarod test
The rotarod test was used to assess motor coordination and balance alterations. The apparatus consisted of a black striated rod separated in four compartments (Model 755, IITC Life Science Inc., Woodland Hills, CA). Animals were first habituated to a stationary rod for 2 min, then placed on a rotating drum accelerating from 4 to 40 rpm over a 5-min period. The time the animal stayed on the drum was recorded. Three trials were performed with 15-min interval rest periods. Then, the mice were placed on the rotating drum at 40 rpm/s and observed over 60 s.
The time at which the animal fell off the drum was recorded. Animals were tested on Days 1, 2, 3, 4, and 5 after MCAO.
| Statistical Analysis
All statistical tests were performed using GraphPad Prisim 6.0 or Sig- (Figure 3a) . In contrast, the Nhe1 KO mice exhibited significantly reduced GFAP staining intensity ( Figure 3a) . We further evaluated whether the reduced numbers of GFAP 1 astrocytes represent less astrocyte proliferation. We injected mice with the mitotic marker BrdU at Day 3 after MCAO to determine proliferation when astrocytes are activated. As shown in Figure 3a (lower panel), the control mice showed significantly higher Brdu 1 / GFAP 1 cells in the ischemic perilesion area than the Nhe1 KO brains.
These data suggest that deletion of astrocytic Nhe1 also inhibits reactive astrocyte proliferation after ischemic stroke.
Moreover, selective knockout of astrocytic Nhe1 in GFAP 1 astrocytes preserves S100b expression. Figure 3b shows that in the CL regions of both the control brains and Nhe1 KO brain, S100b 1 cells spread throughout the brain parenchyma (arrows). Astrocytes express S100b in the cell bodies and thin processes. After 48 hr of reperfusion, loss of S100b and increased GFAP expression (arrow head) were seen in the perilesion areas of the control mice. In contrast, the Nhe1 KO ischemic brains exhibited preserved S100b expression and lack of GFAP 1 astrogliosis (arrows).
We further quantified changes of reactive astrocyte morphology in the control and Nhe1 KO ischemic brains. Representative confocal Z stacks of GFAP-stained images in the peri-lesion area were taken and analyzed ( Figure 3c ). GFAP 1 astrocytes in the control brains had highly ramified morphology with increase in the astrocyte soma volume (15 6 0.2 lm ;Nhe1 f/f mice preserves perivascular astrocyte function and microvessel tight junction structure.
We then determined whether Nhe1 KO mice show improved BBB integrity by testing its permeability to high-molecular-weight protein albumin extravasation in the brain parenchyma. As shown in Figure 4d , EB leakage was minimal at 24 hr reperfusion in both CL hemisphere tissues of the oil-and Tam-treated mice. However, EB leakage was markedly increased in the IL cortex of the control brains. In contrast, no significant leakage of EB was detected in Nhe1 KO brains (Figure 4d) . immunoreactive signals was located at the astrocyte endfeet and colocalized with AQP4 in the endothelial cells bordering the vessels (Figure 5a, arrows) . In contrast, no MMP-9-positive signals were detected in the IL regions of Nhe1 KO mouse brains (Figure 5a , arrow heads).
These findings strongly suggest that deletion of Nhe1 in GFAP 1 astrocytes ameliorates MMP-9 secretion/activation upon ischemic stroke.
3.6 | Deletion of Nhe1 in Gfap-Cre ER1/2 ;Nhe1 f/f mice exhibit reduced perivascular damage and increased micro vessel density after ischemic stroke
We employed aquaporin 4 (AQP4) immunocytochemical analyses to study the extent of micro vessel damage upon ischemia in control and Nhe1 KO mice. Figure 6a shows that the IL cortex exhibited an increase in the number of perivascular reactive GFAP 1 astrocytes, which are closely associated with AQP4-stained microvessels at the peri-lesion areas (arrow, white box). Strikingly, elevated GFAP 1 expression and hypertrophic AQP4 1 astrocytic endfoot processes were colocalized in the dilated blood vessels of the control brains (arrow, Figure 6a) . In contrast, the Nhe1 KO brains appeared to show less expression of AQP4 and less co-localization of AQP4 and GFAP immunosignals in the perivascular astrocyte processes, but there are no statistically significant differences (Supporting Information, Figure 3 ).
In evaluation of the perivascular AQP4-labeled vessels, we observed differences in the change of microvessel density and branching between control and Nhe1 KO ischemic brains. At 2 days after ischemic stroke, AQP4-labeled microvessels were decreased or nearly abolished in the ischemic core (Figure 6b (i) ). Vascular density reductions also occurred in the ischemic perilesion areas. However, a significant loss of microvasculature density in the ischemic perilesion areas was detected only in the control but not in the Nhe1 KO mice (Figure 6c (i) ). Interestingly, deletion of astrocytic Nhe1 profoundly preserved larger microvessels (>100 mm in length) with less effect on small vessels (<70 mm in length, Figure 6c (ii)). We also performed the quantification of microvessels by immunostaining for endothelial cell specific marker glucose transporter 1 (GLUT1). As shown in Figure 6c (iii, iv) and Supporting Information, Figure 4 , the Nhe1 KO mice illustrated significant higher density of larger microvessels in the ischemic peri-lesion areas at 48 hr of reperfusion, compared with that in control mouse brains. This is consistent with the findings using the analysis of the AQP4-stained microvessels. These results suggest that deletion of Nhe1 gene in GFAP 1 astrocytes preserved the density of microvessels in the ischemic brains.
3.7 | Astrocytic Nhe1 KO mice exhibit improved regional collateral blood flow (rCBF) after ischemic stroke of red blood cells in the cortical vessels, which provides information about changes of cerebral blood perfusion over time. Baseline measurements were recorded over a 5-min period prior to subjecting the animals to the MCAO. Immediately following vessel occlusion or upon reperfusion, rCBF was recorded at 5-min intervals. Figure 7a shows the representative images of cerebral perfusion in the control and Nhe1 KO mice. A significant decrease of rCBF from the baseline within the IL hemisphere was detected in both control (88.1 6 11.4 vs 246.9 6 24.5, p < .0001) and Nhe1 KO mice (92.3 6 8.4 vs 232.0 6 18.8, p < .0001) at 60-min post-MCAO (Figure 7b ). Interestingly, a significantly higher perfusion was observed at 24 hr of reperfusion in Nhe1 KO mice than in control mice (220.0 6 10.4 vs 174.6 6 7.0, p < .01).
These findings further suggest that Nhe1 KO mice exhibited higher cerebral perfusion, which could result from improved microvessel density and improved collateral flow.
| Changes of pH i and gene expression in Nhe1 KO astrocytes
To further understand the impact of NHE1 in astrocyte pH i regulation, we measured changes of pH i in astrocytes in acutely isolated cortical slices from the Con and Nhe1 KO mice. Astrocytes in the slice loaded with a pH indicator SNARF-5F were identified by their selective uptake of SR101 dye ( Supporting Information, Figure 5a ). The basal pH i of astrocytes in the presence of HEPES-buffered solution (pH 7.4, CO 2 / HCO 3 -free) was calculated as 7.8 6 0.2 in the Con brains and 7.9 6 0.2 in the Nhe1 KO brains (Supporting Information, Figure 5a-d) . These values are in agreement with previously reported alkaline basal pH i values (7.5-7.7) in the brain slices (Lin et al., 1996) . Upon 2 min exposure to chemical ischemia (NaN3, 2-deoxyglucose), reduction in pH i was detected in both Con astrocytes (0.4 6 0.03 pH units) and Nhe1 KO activity is blocked by its inhibitor EIPA (Theparambil, Ruminot, Schneider, Shull, & Deitmer, 2014) . Even when using HEPES-buffered solution (pH 7.4, CO 2 /HCO 3 -free), NBCe1 in astrocytes remains active with sufficient residual interstitial HCO 3 levels (Brookes & Turner, 1994; Theparambil et al., 2014) . In contrast, it may require longer ischemic challenge to determine the impact of deleting astrocyte Nhe1 on astrocyte pH i as we detected NHE1-dependent pH i recovery at 15-min reoxygenation following 2 hr OGD in astrocyte cultures (Kintner et al., 2004) . Taken together, additional studies are needed to investigate impact of deleting astrocyte Nhe1 in pH i regulation following ischemia and possible activation of other pH regulatory mechanisms including NBCe1, and the voltage-gated proton channel Hv1, both of which mRNAs were detected in astrocytes in our study.
| D I SCUSSION
| NHE1 activation is required for astrogliosis after ischemic stroke
The hallmarks of reactive astrogliosis after ischemic injury include a pronounced increase in expression of GFAP and astrocyte hypertrophy that occurs over the first few days, along with scar formation by ten days (Ding, 2014) . Activation of NHE1 protein may be essential for forming reactive astrocytes. A positive correlation between NHE1 activation and reactive astrocyte formation has been observed in hippocampal astrocytes after in vitro ischemia (Cengiz et al., 2014) .
Upregulation of NHE1 protein in reactive astrocytes is also detected in ischemic brains (Shi, Chanana, Watters, Ferrazzano, & Sun, 2011) . In this study, establishing the Gfap-Cre decipher the direct role of astrocytic NHE1 in reactive astrocyte formation and in neurological damage after ischemic stroke. We demonstrated that the astrocytic Nhe1 KO mice were healthy and did not show any discernible phenotypes. After acute ischemic stroke, Nhe1 KO mice exhibited significantly reduced reactive astrogliosis, attenuated hypertrophy, and reduced BrdU 1 labeling in GFAP 1 cells in the peri-ischemic region of ischemic brains. These findings suggest that NHE1 protein is involved in astrocyte proliferation.
NHE1-mediated change in pH i and/or intracellular Na 1 concentration is important for the regulation of cell proliferation (Nakamura et al., 2008) . Intracellular alkalinization-mediated by NHE1 activation is required for efficient progression from S to G2/M phase (Putney & Barber, 2003) . Studies have also shown that H 1 ion translocation by NHE1 is necessary for controlling both the activity and expression of various M phase regulators, including cyclin B1 and the cyclindependent kinases (Cdks), in promoting mitotic activity (Putney et al., 2003) . In this study, we conducted initial RNAseq analysis of GFAP 1 astrocytes and found key cell proliferation genes, such as Cdk7, Cdk12, Cdk18, and Cdkn1a, were significantly elevated in the control brains at 24 hr post-MCAO (Supporting Information, Figure 6 ). In contrast, the Nhe1 KO astrocytes expressed significantly lower amounts of these key Cdk genes (Supporting Information, Figure 6 ). CDK7 is an important component of activated CDK complex that regulates cell cycle progression (Wu, Stoica, & Faden, 2011; Wang et al., 2016) . Administration of CDK inhibitors reduces the aberrant cell cycle activation and ischemia-induced reactive astrogliosis (Byrnes et al., 2007; Hilton, Stoica, Byrnes, & Faden, 2008; Zhu et al., 2007) . Thus, our findings suggest that NHE1 protein affects a check point that controls the key cell cycle activator gene expression in GFAP 1 astrocytes. Therefore, selective deletion of Nhe1 in GFAP 1 astrocytes inhibits astrogliosis in part by decreasing cell cycle gene transcription and astrocyte proliferation after ischemic stroke.
| NHE1 activation in astrocyte dysfunction after ischemic stroke
Our study illustrated that deletion of Nhe1 in astrocytes is associated with reduced reactive astrogliosis and less ischemic brain damage. We speculate that may result from reducing astrocyte death and preserving normal astrocyte function in ischemic brains. Astrocytes regulate uptake and release of many signaling molecules including growth factors, cytokines, neurotransmitters, and ATP (Sofroniew, 2009 ).
Hypoxia, extracellular acidosis, and reduction of extracellular Na 1 concentration (shifts of cellular Na 1 gradient) lead to astrocyte death (Bondarenko & Chesler, 2001a , Bondarenko & Chesler, 2001b . The underlying mechanisms involve toxic intracellular Na 1 overload mediated by activation of NHE1 protein and reverse mode operation of the Na 1 /Ca 21 exchanger (Bondarenko & Chesler, 2001a; Rose, Waxman, & Ransom, 1998 (Bondarenko & Chesler, 2001a; Kintner et al., 2004) . Therefore, the neuroprotective effects seen in this study by deletion of Nhe1 in astrocytes are likely due to reduced intracellular Na 1 overload, decreased astrocyte death, and restoration of normal astrocyte functions. This view is further supported by our S100b data. Brain injury triggers astrocytes to release S100b protein into the extracellular space (Morrison & Filosa, 2016) .
Elevated S100b levels have been detected in CSF and serum samples after ischemic stroke and traumatic head injuries, which correlates with severity of brain damage (Sun, Liu, & Nie, 2013; Vos et al., 2010) . In our study, we found that S100b protein is preserved in the GFAP 1 cell soma of Nhe1 KO brains and, in contrast, extensive loss of S100b from GFAP 1 cells was detected in control mouse brains. Recent findings show that preventing astrocyte scar formation, attenuating scar forming astrocytes, or ablating chronic astrocytic scars blocks CNS axon regeneration, and exacerbates neurological functional deficits in spinal cord injury, brain injury, or experimental autoimmune encephalomyelitis models (Anderson et al., 2016) . Our study suggests that NHE1 activity is an important contributing factor for astrocyte dysfunction, and targeting NHE1 presents a better strategy in maintaining normal astrocytic homeostasis and function.
| Roles of NHE1 in perivascular astrocyte endfeet and AQP4 expression
Astrocyte endfeet together with pericytes and basal lamina play an important role in the regulation of rCBF and maintenance of BBB integrity (Attwell et al., 2010; Haydon & Carmignoto, 2006; Liebner, Czupalla, & Wolburg, 2011; Takano et al., 2006) . The endfeet of astrocytes are densely packed with AQP4 and allow astrocytes to regulate the transport of water and other substances between the intravascular space and brain parenchyma (Iliff et al., 2012; Iliff & Negergaard, 2013; Yang et al., 2013) . AQP4 also plays a major role in ischemic edema after ischemia (Fu, Li, Feng, & Mu, 2007; Manley et al., 2000; Papadopoulos, Manley, Krishna, & Verkman, 2004a , Papadopoulos et al., 2004b Ribeiro Mde, Hirt, Bogousslavsky, Regli, & Badaut, 2006) .
Increased AQP4 expression has been demonstrated to coincide with perivascular astrocyte swelling (Manley et al., 2000) . In a mouse model of transient cerebral ischemia, AQP4 expression was upregulated in the perivascular endfeet at 1 hr post-occlusion and correlated with cerebral swelling in the core and border of the lesion (Ribeiro Mde et al., 2006) . AQP4 expression in cultured astrocytes is enhanced by lactic acidosis after ischemia (Morishima et al., 2008) . Although disruption of AQP4 anchoring proteins or deletion of AQP4 from perivascular astrocytes in mice leads to a reduction in cerebral edema after ischemic stroke (Amiry-Moghaddam et al., 2003; Manley et al., 2000; Zeynalov et al., 2008; Zeng et al., 2010) , deletion of AQP4 also increases vasogenic edema upon ischemic stroke (Papadopoulos & Verkman, 2013; Saadoun & Papadopoulos, 2010) . These findings suggest that AQP4-mediated cellular damage in ischemic stroke is complicated and associated with other biochemical changes.
In our study, an increased number of perivascular astrocytes with (Staub, Baethmann, Peters, Weigt, & Kempski, 1990; Yao, Gu, Douglas, & Haddad, 2001) . We have previously shown that pharmacological inhibition of NHE1 in astrocytes reduces the rise in Na 1 and swelling after in vitro ischemia (Kintner et al., 2004) . Therefore, deletion of astrocytic Nhe1 may decrease ischemic edema by several mechanisms, including reducing astrocytic inflammation, AQP4 expression, and astrocyte swelling. (Bauer, Burgers, Rabie, & Marti, 2010; Liu, Jin, Liu, & Liu, 2012; Tavelin et al., 2003) . We did not detect any changes in the expression of claudin-5 protein in the two treatment groups (data not shown). Therefore, deleting astrocytic Nhe1 may preserve BBB integrity in part by maintaining occludin expression and TJ structures in ischemic brains.
Activated astrocytes secrete chemokines (MCP-1, Rantes), proand anti-inflammatory cytokines (IL-1a, IL-1b, TNFa, interferon-g), and growth factors (TGF-b), which are known to directly damage the cerebral endothelium and disrupt the BBB (Doyle, Cekanaviciute, Mamer, & Buckwalter, 2010; Lau & Yu, 2001; Lee et al., 2007; Ronaldson & Davis, 2012; Vangilder, Rosen, Barr, & Huber, 2011) . Increased NHE1 activity in astrocytes aggravates proinflammatory stimulation (Cengiz et al., 2014) . Increased Ca 21 influx activates many signaling pathways and molecular events, especially calpain proteases and MMPs, which are widely regarded as hallmarks of the breakdown of the BBB (Cao et al., 2007; Gu et al., 2002; Zhao et al., 2006 (Kintner, Wang, & Sun, 2007) . During the acute phase of postischemic stroke, increased NHE1 activity may contribute to high influx of Ca 21 at the astrocyte endfeet and damage to the BBB. Thus, the better-preserved TJ structure and BBB function in Nhe1 KO mouse brains may result from decreased MMP activation at the BBB.
| Association between NHE1 and MMP9 in ischemic brains
In acute ischemia, activation of MMPs (especially, MMP-9) causes neurovascular matrix degradation, BBB disruption leading to edema, and increased inflammation (Dejonckheere, Vandenbroucke, & Libert, 2011; Horstmann, Kalb, Koziol, Gardner, & Wagner, 2003; Montaner et al., 2003; Planas, Sole, & Justicia, 2001; Rosell & Lo, 2008; Yang, Estrada, Thompson, Liu, & Rosenberg, 2007) . Activated astrocytes are the most important source of MMP-9 during brain injury (Zhang & Chintala, 2004; Tejima et al., 2007) . Increased MMP-9 is known to cause cleavage of basement membrane laminin and degradation of the TJ protein occludin (Liu et al., 2012) . We found increased perivascular expression of MMP-9 protein and degradation of microvessel laminin in the control brains, but deletion of astrocytic Nhe1 abolished upregulation of MMP-9 expression in the perivascular astrocyte endfeet. Activation of MMP-9 depends on various factors including circulating inflammatory cytokines, endogenous tPA, and oxygen-free radicals (Amantea et al., 2014; Gasche, Copin, Sugawara, Fujimura, & Chan, 2001; Gu et al., 2002; Turner & Sharp, 2016) . In addition, acidic extracellular pH (pH e ) is also known to trigger MMP-9 expression via the NFkB pathway as the NFkB and AP-1 binding sites of the MMP-9 promoter are sensitive to acidic pH e (Kato et al., 2005) . Focal cerebral ischemia causes a rapid fall in pH e from 7.2 to below 6.6 (Nedergaard, Kraig, Tanabe, & Pulsinelli, 1991) and increased NHE1 activity accelerates H 1 efflux in astrocytes (Kintner et al., 2007) . Based on these observations, deletion of astrocytic Nhe1 may reduce the perivascular expression and function of MMP-9 via multiple mechanisms in the Nhe1 KO brains.
4.6 | Astrocytic NHE1 protein in regulating cerebral vascular function after ischemic stroke Vascular remodeling after stroke is a critical determinant of stroke outcome (Gertz et al., 2006 (Gertz et al., , 2012 . Angiogenesis through new blood vessel formation results in improved collateral circulation and has an impact on the long-term recovery of stroke patients (Font, Arboix, & Krupinski, 2010; Slevin, Kumar, Gaffney, Kumar, & Krupinski, 2006 ).
Our results demonstrate that deletion of Nhe1 in the Gfap CreER/1 ; Nhe1 f/f brains leads to improved rCBF and higher microvessel density (especially larger microvessels) in the ischemic perilesion area. We speculate that deletion of astrocytic Nhe1 may preserve vascular function by reducing ischemia-induced vascular damage at the BBB. In addition, the Nhe1 KO mouse brain may exhibit altered expression and secretion of angiogenic factors from astrocytes that stimulate angiogenesis and long-term vascular remodeling. Additional studies are required to investigate these cellular and molecular mechanisms and identify the specific factors involved. Taken together, our findings demonstrate that selective deletion of the astrocytic Nhe1 gene reduces cerebral microvessel damage and improves rCBF after acute ischemic stroke in mice.
| C ONC LUSI ON S
In summary, previous studies have shown that pharmacological inhibition of NHE1 protein with its inhibitors has neuroprotective effects in experimental stroke models (Luo et al., 2005; Shi et al., 2011) . Here, we show for the first time that astrocytic NHE1 protein plays a critical role in reactive astrogliosis and neurovascular damage after ischemic stroke. By using inducible, astrocyte-specific Gfap-Cre 
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